María Carmen Riesco Martínez

A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer

Richard D. Kim, Bence Kővári, María Carmen Riesco Martínez et al. · European Journal of Cancer · 2022 · 85 citations

Medicine, Refractory Colorectal Cancer, Pathology +6

Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study

Mónica P. Cala, M. Teresa Agulló-Ortuño, Elena Prieto‐García et al. · Journal of Cachexia Sarcopenia and Muscle · 2018 · 83 citations · Full text

VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects

Miriam Bazán‐Peregrino, Rocio García‐Carbonero, Berta Laquente et al. · Journal for ImmunoTherapy of Cancer · 2021 · 82 citations · Full text

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors

Rocio García‐Carbonero, Miriam Bazán‐Peregrino, Marta Gil-Martín et al. · Journal for ImmunoTherapy of Cancer · 2022 · 75 citations · Full text

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Ángela Lamarca et al. · Journal of Clinical Oncology · 2019 · 69 citations · Full text